Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin

Summary

The purpose of this study was to observe change of HbA1c over time from baseline to month 12. The ultimate goal of this study was to provide a local reference value to the physicians \& patients in the future when they consider initiating Vildagliptin and taking balance between efficacy, compliance, risk factors, convenience and medication cost.

Timeline

Start

2013-05-13

Primary completion

2015-10-22

Completion

2015-10-22

Drugs

Indications